Glenn L. Cooper M.D., Director at REPLIGEN CORP (RGEN), sold 9,734 shares at $66.91 ($651K) on 2019-05-23, disclosed to the SEC on 2019-06-19.
Open-market sale of $651k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.91 | 4,734 | $317K | 48.6% |
| 2 | $66.91 | 4,734 | $317K | 48.6% |
| 3 | $67.53 | 266 | $18K | 2.8% |
| Total | $66.93 avg | 9,734 | $651K | 100% |
| Filing → |
| CNDO | BUY | 2012-06-26 | $53K | — | Filing → |
| RGEN | BUY | 2009-11-17 | $25K | — | Filing → |
| IDEV | BUY | 2006-01-09 | $59K | — | Filing → |